Evidence map›Paper›PMID 30594952›Full record

ReviewApplied microbiology and biotechnology2019

Streptomyces: implications and interactions in plant growth promotion.

Oluwaseyi Samuel Olanrewaju, Olubukola Oluranti Babalola

Abstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 170 papers.

0numbers the graph read from it
0cells of the map it votes in
170citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

170 citing papers in PubMed.

  1. Characterization of a CYP107 family vitamin DArchives of biochemistry and biophysics · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Studies on Secondary Metabolites ofPolish journal of microbiology · 2025
    Article

110 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Oluwaseyi Samuel OlanrewajuFood Security and Safety Niche Area, Faculty of Natural and Agriculture Sciences, North-West University, Mmabatho, 2735, South Africa.ORCID http://orcid.org/0000-0002-1682-1060
Olubukola Oluranti BabalolaFood Security and Safety Niche Area, Faculty of Natural and Agriculture Sciences, North-West University, Mmabatho, 2735, South Africa. Olubukola.Babalola@nwu.ac.za.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the impending increase of the world population by 2050, more activities have been directed toward the improvement of crop yield and a safe environment. The need for chemical-free agricultural practices is becoming eminent due to the effects of these chemicals on the environment and human health. Actinomycetes constitute a significant percentage of the soil microbial community. The Streptomyces genus, which is the most abundant and arguably the most important actinomycetes, is a good source of bioactive compounds, antibiotics, and extracellular enzymes. These genera have shown over time great potential in improving the future of agriculture. This review highlights and buttresses the agricultural importance of Streptomyces through its biocontrol and plant growth-promoting activities. These activities are highlighted and discussed in this review. Some biocontrol products from this genus are already being marketed while work is still ongoing on this productive genus. Compared to more focus on its biocontrol ability, less work has been done on it as a biofertilizer until recently. This genus is as efficient as a biofertilizer as it is as a biocontrol.

Indexed as

Crop ProductionBiological Control AgentsFertilizersPlant DevelopmentPlantsStreptomycesBiological Control AgentsFertilizersActinomycetesBiocontrolBiofertilizerStreptomycesSustainable agricultureVOCs

Identifiers

PMID30594952
PMCPMC6394478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.